Marshall, R. D., Beebe, K. L., Oldham, M., & Zaninelli, R. (2001). Efficacy and safety of paroxetine treatment for chronic PTSD. A fixed dose, placebo-controlled study. The American Journal of Psychiatry, 158, 1982–1988.CrossRefPubMed

Martenyi, F., & Soldatenkova, V. (2006). Fluoxetine in the acute treatment and relapse prevention of combat-related post-traumatic stress disorder: Analysis of the veteran group of a placebo-controlled, randomized clinical trial. European Neuropsychopharmacology, 16(5), 340–349.CrossRefPubMed

Martenyi, F., Brown, E. B., Zhang, H., et al. (2002). Fluoxetine v. placebo in prevention of relapse in post-traumatic stress disorder. British Journal of Psychiatry, 181, 315–320.CrossRefPubMed

Martenyi, F., Brown, E., & Caldwell, C. (2007). Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: Results of a fixed-dose, placebo-controlled study. Journal of Clinical Psychopharmacology, 27(2), 166–170.CrossRefPubMed

McGhee, L. L., Maani, C. V., Garza, T. H., DeSocio, P. A., Gaylord, K. M., & Black, I. H. (2009). The relationship of intravenous midazolam and posttraumatic stress disorder development in burned soldiers. Journal of Trauma, 66(4 Suppl), S186–S190.CrossRefPubMed

McRae, A. L., Brady, K. T., Mellman, T. A., Sonne, S. C., Killeen, T. K., Timmerman, M. A., et al. (2004). Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder. Depression and Anxiety, 19(3), 190–196.CrossRefPubMed

Monnelly, E. P., Ciraulo, D. A., Knapp, C., & Keane, T. (2003). Low-dose risperidone as adjunctive therapy for irritable aggression in posttraumatic stress disorder. Journal of Clinical Psychopharmacology, 23, 193–196.CrossRefPubMed

National Institute for Health and Care Excellence. (2005). Post-traumatic stress disorder: The management of PTSD in adults and children in primary and secondary care (Report No.: NICE clinical guidelines, No. 26), London, Available online at: http://​guidance.​nice.​org.​uk/​CG26. Accessed 15 Dec 2013.

Neal, L. A., Shapland, W., & Fox, C. (1997). An open trial of moclobemide in the treatment of post-traumatic stress disorder. International Clinical Psychopharmacology, 12, 231–237.CrossRefPubMed

Padala, P. R., Madison, J., Monnahan, M., Marcil, W., Price, P., Ramaswamy, S., et al. (2006). Risperidone monotherapy for post-traumatic stress disorder related to sexual assault and domestic abuse in women. International Clinical Psychopharmacology, 21, 275–280.CrossRefPubMed

Panahi, Y., Moghaddam, B. R., Sahebkar, A., et al. (2011). A randomized, double-blind, placebo-controlled trial on the efficacy and tolerability of sertraline in Iranian veterans with post-traumatic stress disorder. Psychological Medicine, 41(10), 2159–2166.CrossRefPubMed

Pollack, M. H., Hoge, E. A., Worthington, J. J., et al. (2011). Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: A randomized double-blind placebo controlled trial. Journal of Clinical Psychiatry, 72, 892–897.CrossRefPubMed